- Home
- FBIO vs NAUT Comparison
FBIO vs NAUT Comparison
Compare FBIO & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- NAUT
- Stock Information
- Founded
- FBIO 2006
- NAUT 2016
- Country
- FBIO United States
- NAUT United States
- Employees
- FBIO N/A
- NAUT N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- FBIO Health Care
- NAUT Industrials
- Exchange
- FBIO Nasdaq
- NAUT Nasdaq
- Market Cap
- FBIO 88.7M
- NAUT 104.7M
- IPO Year
- FBIO N/A
- NAUT N/A
- Fundamental
- Price
- FBIO $2.75
- NAUT $2.28
- Analyst Decision
- FBIO Strong Buy
- NAUT Strong Sell
- Analyst Count
- FBIO 2
- NAUT 1
- Target Price
- FBIO $16.50
- NAUT $1.75
- AVG Volume (30 Days)
- FBIO 341.4K
- NAUT 544.3K
- Earning Date
- FBIO 11-14-2025
- NAUT 10-28-2025
- Dividend Yield
- FBIO N/A
- NAUT N/A
- EPS Growth
- FBIO N/A
- NAUT N/A
- EPS
- FBIO N/A
- NAUT N/A
- Revenue
- FBIO $62,303,000.00
- NAUT N/A
- Revenue This Year
- FBIO $31.85
- NAUT N/A
- Revenue Next Year
- FBIO $44.43
- NAUT N/A
- P/E Ratio
- FBIO N/A
- NAUT N/A
- Revenue Growth
- FBIO N/A
- NAUT N/A
- 52 Week Low
- FBIO $1.33
- NAUT $0.62
- 52 Week High
- FBIO $4.20
- NAUT $2.54
- Technical
- Relative Strength Index (RSI)
- FBIO 55.02
- NAUT 65.23
- Support Level
- FBIO $2.40
- NAUT $2.00
- Resistance Level
- FBIO $2.76
- NAUT $2.26
- Average True Range (ATR)
- FBIO 0.16
- NAUT 0.22
- MACD
- FBIO 0.03
- NAUT 0.02
- Stochastic Oscillator
- FBIO 94.59
- NAUT 76.55
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.